Generic name: ESZOPICLONE 1mg
Dosage form: tablet, coated
Drug class: Miscellaneous anxiolytics, sedatives and hypnotics
Medically reviewed by Drugs.com. Last updated on Sep 13, 2021.
Use the lowest effective dose for the patient.
Dosage in Adults
The recommended starting dose is 1 mg. Dosing can be raised to 2 mg or 3 mg if clinically indicated. In some patients, the higher morning blood levels of LUNESTA following use of the 2 mg or 3 mg dose increase the risk of next day impairment of driving and other activities that require full alertness [see Warnings and Precautions (5.1)]. The total dose of LUNESTA should not exceed 3 mg, once daily immediately before bedtime [see Warnings and Precautions (5.6)].
Geriatric or Debilitated Patients
The total dose of LUNESTA should not exceed 2 mg in elderly or debilitated patients.
Patients with Severe Hepatic Impairment, or Taking Potent CYP3A4 Inhibitors
In patients with severe hepatic impairment, or in patients coadministered LUNESTA with potent CYP3A4 inhibitors, the total dose of LUNESTA should not exceed 2 mg [see Warnings and Precautions (5.7)].
Use with CNS Depressants
Dosage adjustments may be necessary when LUNESTA is combined with other central nervous system (CNS) depressant drugs because of the potentially additive effects [see Warnings and Precautions (5.1)].
Administration with Food
Taking LUNESTA with or immediately after a heavy, high-fat meal results in slower absorption and would be expected to reduce the effect of LUNESTA on sleep latency [see Clinical Pharmacology (12.3)].
Frequently asked questions
More about Lunesta (eszopiclone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (314)
- Drug images
- Latest FDA alerts (3)
- Side effects
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.